Skip to main content

Advertisement

Log in

Extremely Well-Differentiated Gastric Adenocarcinoma Arising in Pylorus with Minor Diffuse Adenocarcinoma Component

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Ferlay J SH, Bray F, Forman D, Mathers C, Parkin DM (2010) Cancer incidence and mortality worldwide: IARC CancerBase No.10

  2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta pathologica et microbiologica Scandinavica. 1965;64:31–49.

    Article  CAS  PubMed  Google Scholar 

  3. Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol. 1999;30(7):826–32.

    Article  CAS  PubMed  Google Scholar 

  4. Yao T, Utsunomiya T, Oya M, Nishiyama K, Tsuneyoshi M. Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features. World J Gastroenterol: WJG. 2006;12(16):2510–6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yamamoto J, Ohshima K, Kohno S, Ichimiya H, Nakagaki M, Yao T, Iwasaki H, Ikeda S. Extremely well differentiated adenocarcinoma of the stomach diagnosed preoperatively as esophageal achalasia: report of a case. Surg Today. 2005;35(6):488–92. doi:10.1007/s00595-004-2944-9.

    Article  PubMed  Google Scholar 

  6. Hoff P, Tabernero J, Shen L, Ohtsu A, Yu R, Szado T, Kang Y-K (2013) P-0111Pertuzumab, trastuzumab and chemotherapy in HER2-positive metastatic gastric or gastro-oesophageal junction cancer: an international phase III study (JACOB). Annals of Oncology 24 (suppl 4):iv67. doi: 10.1093/annonc/mdt203.109

  7. Terada T. Well differentiated adenocarcinoma of the stomach composed of chief cell-like cells and parietal cells (gastric adenocarcinoma of fundic gland type). Int J Clin Exp Pathol. 2011;4(8):797–8.

    PubMed  PubMed Central  Google Scholar 

  8. Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, Iwashita A, Watanabe S. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34(5):609–19. doi:10.1097/PAS.0b013e3181d94d53.

    PubMed  Google Scholar 

  9. Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, Tatematsu M. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57(8):517–22. doi:10.1111/j.1440-1827.2007.02134.x.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jasna Bacalja.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

A part of the article was presented as poster presentation named Extremely well-differentiated gastric adenocarcinoma in a 40-year-old patient by authors Z. Jukić, Z. Marušić, J. Kristek and M. Bekavac-Bešlin at a scientific meeting, 1st IASGO (International Association of Surgeons, Gastroenterologists and Oncologists) Croatia Course, the Red Island, Rovinj, Croatia, April 26th–28th 2013.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jukić, Z., Bacalja, J., Kristek, J. et al. Extremely Well-Differentiated Gastric Adenocarcinoma Arising in Pylorus with Minor Diffuse Adenocarcinoma Component. J Gastrointest Canc 49, 75–77 (2018). https://doi.org/10.1007/s12029-016-9851-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-016-9851-3

Keywords

Navigation